{"id":1663,"date":"2020-09-11T13:04:07","date_gmt":"2020-09-11T17:04:07","guid":{"rendered":"http:\/\/carolinaurologicresearchcenter.com\/?p=1663"},"modified":"2020-09-15T12:13:23","modified_gmt":"2020-09-15T16:13:23","slug":"nonmetastatic-castration-resistant-prostate-cancer-and-survival-with-darolutamide","status":"publish","type":"post","link":"https:\/\/carolinaurologicresearchcenter.com\/nonmetastatic-castration-resistant-prostate-cancer-and-survival-with-darolutamide\/","title":{"rendered":"Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide"},"content":{"rendered":"
Karim Fizazi, M.D., Neal Shore, M.D., Teuvo L. Tammela, M.D., Ph.D., Albertas Ulys, M.D., Egils Vjaters, M.D., Sergey Polyakov, M.D., Mindaugas Jievaltas, M.D., Murilo Luz, M.D., Boris Alekseev, M.D., Iris Kuss, M.D., Marie-Aude Le Berre, M.Sc., Oana Petrenciuc, M.D., et al., for the ARAMIS Investigators*<\/p>\n